VIVIMED LABS Fact Sheet, VIVIMED LABS Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

VIVIMED LABS Fact Sheet    (VIVI)


Watch Now: The Great Indian Wealth Project


Here is the latest financial fact sheet of VIVIMED LABS. For more details, see the VIVIMED LABS quarterly results and VIVIMED LABS share price and chart. For a sector overview, read our pharmaceuticals sector report.

VIVIMED LABS Price History

Price Rs 19.3
Mkt Cap Rs m 1,596
Vol '000 34.0
P/E X -1.6
P/CF X -3.8
EPS (TTM) Rs -12.4
% ch % 0.8
No. of shares m 82.91
% ch week % 2.9
% ch 1-mth % -2.8
% ch 12-mth % 6.9
52 week H/L Rs 41.5/12.9
(As on Dec 8, 2021 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

VIVIMED LABS Financials

No. of Mths
Year Ending
12
Mar-16
*
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
12
Mar-20
*
5-Yr Chart
Click to enlarge
VIVIMED LABS EQUITY SHARE DATA
High Rs4854301538227 
Low Rs1756867207 
Sales per share (Unadj.) Rs830.6180.4143.7159.4127.7 
Earnings per share (Unadj.) Rs51.726.49.27.0-13.2 
Diluted earnings per shareRs10.125.89.26.9-13.2 
Cash flow per share (Unadj.) Rs89.533.616.115.0-5.1 
Dividends per share (Unadj.) Rs00.400.4000 
Adj. dividends per shareRs0.000.390.400.000.00 
Avg Dividend yield %00.20.400 
Book value per share (Unadj.) Rs361.290.6148.6114.4100.7 
Adj. book value per shareRs70.688.6147.9113.8100.7 
Shares outstanding (eoy) m16.2081.0282.5282.5282.91 
Bonus / Rights / Conversions  ----- 
Price / Sales ratio x0.41.40.80.30.1 
Avg P/E ratio x6.49.411.97.4-1.3 
P/CF ratio (eoy) x3.77.46.93.4-3.3 
Price / Book Value ratio x0.92.70.70.40.2 
Dividend payout %01.54.300 
Avg Mkt Cap Rs m5,34720,1749,0904,2231,405 
No. of employees `000NANANANANA 
Total wages/salary Rs m1,7691,9001,9782,4182,334 
Avg. sales/employee Rs ThNMNMNMNMNM 
Avg. wages/employee Rs ThNMNMNMNMNM 
Avg. net profit/employee Rs ThNMNMNMNMNM 
VIVIMED LABS INCOME DATA
Net Sales Rs m13,45614,61911,85713,15210,588 
Other income Rs m23681238340119 
Total revenues Rs m13,69314,70012,09413,49110,707 
Gross profit Rs m2,2304,0452,0071,68966 
Depreciation Rs m614583564668669 
Interest Rs m853678824701610 
Profit before tax Rs m9992,865857660-1,095 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m1637259687-4 
Profit after tax Rs m8372,140761574-1,091 
Gross profit margin %16.627.716.912.80.6 
Effective tax rate %16.325.311.213.10.3 
Net profit margin %6.214.66.44.4-10.3 
VIVIMED LABS BALANCE SHEET DATA
Current assets Rs m11,32610,94412,81912,3069,753 
Current liabilities Rs m8,9748,1747,9028,8897,704 
Net working cap to sales %17.518.941.526.019.4 
Current ratio x1.31.31.61.41.3 
Inventory Days Days121130 
Debtors Days Days8850859986 
Net fixed assets Rs m9,1109,61011,03810,91812,206 
Share capital Rs m8021623,4173,4173,418 
"Free" reserves Rs m5,0507,1808,8476,0214,928 
Net worth Rs m5,8527,34212,2649,4388,346 
Long term debt Rs m2,5734,5333,2524,2484,704 
Total assets Rs m20,43720,55523,85823,22421,959 
Interest coverage x2.25.22.01.9-0.8 
Debt to equity ratio x0.40.60.30.50.6 
Sales to assets ratio x0.70.70.50.60.5 
Return on assets %8.313.76.65.5-2.2 
Return on equity %14.329.16.26.1-13.1 
Return on capital %22.029.810.89.9-3.7 
Exports to sales %5.54.436.914.67.0 
Imports to sales %2.21.0000 
Exports (fob) Rs m7376434,3761,922745 
Imports (cif) Rs m302142000 
Fx inflow Rs m1,1588354,3761,922745 
Fx outflow Rs m1,358821125535770 
Net fx Rs m-200134,2511,386-26 
VIVIMED LABS CASH FLOW
From Operations Rs m 1,541 580 214 4,221 796 
From Investments Rs m -1,904 -685 -1,635 -889 -1,960 
From Financial Activity Rs m 406 351 1,857 -3,378 724 
Net Cashflow Rs m 43 245 436 -45 -440 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Promoters 28.6%
Institution 2.0%
Non-Institution 69.5%
Total 100.0%
Free Float 71.4%
Pledged promoter holdings 54.2%
 

Company Information

REGD OFF Plot No 78 - A, Kolar Industrial Area, Bidar - 585403
E-MAIL chanakya@vivimedlabs.com/yugandhar.Kopparthi@vivimedlabs.com WEB www.vivimedlabs.com
TEL 08482-232045 FAX 08482-232436
SECTOR PHARMACEUTICALS GROUP Private sector
TR AGENT Aarthi Consultants Pvt Ltd, 1-2-285, Domalaguda
AUDITOR P. Murali & Co.
CHM: Santosh Varalwar (MD) COMP SEC: Fahim Aslam Khan YEAR OF INC: 1988 BSE CODE: 532660 FV (Rs): 2 DIV YIELD (%): -

More Pharmaceuticals Company Fact Sheets:   SUN PHARMA  LUPIN  CIPLA  AUROBINDO PHARMA  DR. REDDYS LAB  

Compare VIVIMED LABS With:   SUN PHARMA  LUPIN  CIPLA  AUROBINDO PHARMA  DR. REDDYS LAB  




Today's Market

4 Reasons Why Sensex Surged 1,016 Points Today(Closing)

Indian share markets continued their momentum and ended their day on a strong note today.

Views on news

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

Block Deal Disappoints Max Healthcare Shareholders. Stock Falls 6% (Views On News)

Sep 30, 2021

The divestment of 6.6% stake by the promoter is considered to be one of the largest block deals of the market.

More Views on News

Most Popular

Infosys vs TCS: Which is Better? (Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

6 Popular Stocks that Turned into Penny Stocks (Views On News)

Nov 27, 2021

A look at popular stocks that crashed big time and never recovered, i.e. which went from 'Multibaggers to Multibeggers'.

India's Top 5 Monopoly Stocks to Watch Out for (Views On News)

Nov 30, 2021

These 5 companies dominate their sectors with a huge piece of the pie.

6 Penny Stocks that Rallied 1,000%+ in One Year (Views On News)

Dec 6, 2021

These penny stocks shed their penny status by surging 1,000% or more in the last one year.

The Biggest Winners and Losers in India's Transition to Electric Vehicles (Profit Hunter)

Nov 26, 2021

How India's EV transition could be a major headwind for the incumbents.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK VIVIMED LABS

  • Track your investment in VIVIMED LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON VIVIMED LABS

VIVIMED LABS 8-QTR ANALYSIS

COMPARE VIVIMED LABS WITH

MARKET STATS